Allspring Global Investments
CSTL icon

Allspring Global Investments’s Castle Biosciences CSTL Stock Holding History

Allspring Global Investments’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.94M Buy
160,663
+1,492
+0.9% +$48.9K 0.01% 910
2025
Q4 		$6.13M Buy
159,171
+2,658
+2% +$85.7K 0.01% 817
2025
Q3 		$3.56M Sell
156,513
-4,662
-3% -$94.7K 0.01% 930
2025
Q2 		$3.29M Sell
161,175
-56,619
-26% -$1.05M 0.01% 961
2025
Q1 		$4.36M Buy
217,794
+207,761
+2,071% +$5.14M 0.01% 956
2024
Q4 		$267K Buy
10,033
+23
+0.2% +$700 ﹤0.01% 1613
2024
Q3 		$285K Sell
10,010
-741
-7% -$18.9K ﹤0.01% 1612
2024
Q2 		$234K Sell
10,751
-111
-1% -$2.47K ﹤0.01% 1676
2024
Q1 		$241K Buy
10,862
+5,123
+89% +$111K ﹤0.01% 1670
2023
Q4 		$124K Buy
5,739
+5,189
+943% +$91.3K ﹤0.01% 1772
2023
Q3 		$9.29K Sell
550
-377,837
-100% -$6.61M ﹤0.01% 2613
2023
Q2 		$5.19M Buy
378,387
+9,934
+3% +$201K 0.01% 985
2023
Q1 		$8.37M Buy
368,453
+15,623
+4% +$382K 0.01% 837
2022
Q4 		$8.31M Buy
352,830
+588
+0.2% +$13.6K 0.01% 834
2022
Q3 		$9.19M Sell
352,242
-116,600
-25% -$3.27M 0.02% 804
2022
Q2 		$10.3M Buy
468,842
+21,786
+5% +$506K 0.02% 773
2022
Q1 		$20.1M Sell
447,056
-5,672
-1% -$234K 0.03% 665
2021
Q4 		$19.4M Buy
+452,728
New +$23.7M 0.02% 715

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's CSTL Position: Q1 2026 in Review

Allspring Global Investments increased its Castle Biosciences (CSTL) stake by 0.94% in Q1 2026, buying an estimated $48.9K and bringing the position to 160,663 shares worth $3.94M. The position accounts for 0.01% of the portfolio, ranked #910.

Allspring Global Investments first reported a position in CSTL in Q4 2021 and has held it in 18 quarters since. The position peaked at $20.1M in Q1 2022. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Allspring Global Investments held 160,663 shares of Castle Biosciences worth $3.94M as of Q1 2026.
  • Allspring Global Investments bought 1,492 Castle Biosciences shares in Q1 2026, an estimated $48.9K.
  • Castle Biosciences made up 0.01% of Allspring Global Investments's portfolio in Q1 2026, its #910 holding.
  • Allspring Global Investments first reported a position in Castle Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Castle Biosciences position peaked at $20.1M in Q1 2022.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.